The Insides News- The Insides Neo - fistuloclysis, distal feeding, best, alternative to parenteral nutrition, fistula, ostomy, ileostomy, chyme, enteral, oral nutrition, enteromate, intestinal failure, colon cancer, bowel cancer, gut cancer, ostomy appliance, high output, chyme, dehydration, defunctioned, ileus, lars, microbiome, lower interior resection syndrome, incontinent, incontinence, gut health, reversal surgery
The Insides Company and Bluestone Corporation sign Distribution Agreement for Singapore

The Insides Company and Bluestone Corporation sign Distribution Agreement for Singapore

July 4, 2024

Source:The Insides Company Limited

On:4th July 2024

Organisation:The Insides Company Limited, Bluestone Corporation Pte Ltd

The Insides Company, the world-first developer of purpose-built chyme reinfusion devices for severe intestinal failure, announces Bluestone Corporation as the exclusive distributor of its chyme reinfusion devices in Singapore.

Chyme reinfusion therapy (CRT) is a life-saving treatment for patients who have suffered intestinal failure. CRT enables patients to recommence oral feeding, utilizing their chyme to sustain the body’s nutritional requirements. Chyme reinfusion therapy is demonstrated to improve clinical outcomes, accelerate patient recovery and allow for early discharge and patient-managed care in their home environments.

The launch of The Insides Company’s products in Singapore, which has a long-standing history and culture of innovation, represents an important milestone for our entry into the ASEAN markets. It further aligns with the company’s mission statement of refeeding the world and enabling universal access to nutrition.

Garth Sutherland, CEO of The Insides Company, said, “We are delighted to partner with the team at Bluestone Corporation and their experience and knowledge in the market will further the adoption of our products that are already in clinical use in Singapore”

David Loh, General Manager of Bluestone Corporation said “We are overjoyed to join forces with The Insides Company. Our shared vision of enhancing patient outcomes through innovative solutions fuels our excitement and commitment to transforming intestinal care in Singapore. Together, we aim to empower the patients and improve their quality of life.”

About Bluestone Corporation

Incorporated in March 1999, Bluestone Corporation Pte Ltd, is a well-established company dedicated to specializing in providing the best medical solutions at the most affordable cost to the healthcare industry in Singapore & Malaysia. With more than 20 years of experience behind us, we are well known for our commitment in providing good and comprehensive education and training programs on the latest medical technology and solutions.

About The Insides Company

The Insides Company Limited is a leading provider of automated chyme reinfusion solutions for the therapeutic treatment of intestinal failure that has resulted from either a high-output enterocutaneous fistula or enterostomy.


Bluestone Corporation Pte Ltd

David Loh, General Manager

Phone:(65) 6767 1311

The Insides® Company Limited

Garth Sutherland, CEO

Phone:+64 9 887 9309

Choose Your Language

Selecting language below will change the language for